Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

DSpace Repository

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

Author: Kemmerer, C. L.; Pernpeintner, V.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Hemmer, B.; Kowarik, M. C.
Tübinger Autor(en):
Ruschil, Christoph
Kemmerer, Constanze Louisa
Abdelhak, Ahmed
Scholl, Matthias
Ziemann, Ulf
Krumbholz, Markus
Kowarik, Markus
Published in: Plos One (2020), Bd. 15, Article e0235449
Verlagsangabe: Public Library Science
Language: English
Full text: http://dx.doi.org/10.1371/journal.pone.0235449
ISSN: 1932-6203
DDC Classifikation: 500 - Natural sciences and mathematics
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)